CRP and non-small cell lung carcinoma: Patients with a surgically treated BM of NSCLC and an admission CRP > 10 mg/L suffered from a significantly higher mortality rate after 12 months compared with patients with a preoperative CRP ≤ 10 mg/L (73% vs. 49%, p = 0.018, OR 2.8).